NHS over next decade and the bonfire of expectations
PharmaTimes Magazine
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
November 2025
In this edition we dare to dream – fever dream, no less – about the future of the NHS. We go beyond the current chaos and speculate about the possibilities built on the founding principles, but without any of the peeling paint and dated equipment. There are also features that focus on the conditions of our times – MND, mental health and even the very skin we live in. Yep, this feels like a pretty important issue, as further deep dives into clinical trials, the top ten drugs of 2025 and the importance of child patient safety so boldly testify. All the regulars complete a stunning line up!
Weight expectations
Bridging the safety gap in online prescribing of GLP-1s
Study session
Strengthening data integrity in trials with subjective endpoints
Safe mode
Reinventing drug safety – pharmacovigilance must evolve
Code bed
How health systems can maintain trust in a world of AI adoption
Risk assessment
The Single National Formulary – friend or foe to pharma?
Prescription pending
Innovation wait – why medicines struggle to reach patients
